News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
246,420 Results
Type
Article (13713)
Company Profile (22)
Press Release (232682)
Multimedia
Podcasts (17)
Webinars (3)
Section
Business (71534)
Career Advice (1121)
Deals (14480)
Drug Delivery (42)
Drug Development (34621)
Employer Resources (47)
FDA (6647)
Job Trends (5814)
News (125650)
Policy (10357)
Tag
Academia (766)
Accelerated approval (7)
Adcomms (7)
Allergies (68)
Alliances (11301)
ALS (74)
Alzheimer's disease (641)
Antibody-drug conjugate (ADC) (135)
Approvals (6835)
Artificial intelligence (211)
Autoimmune disease (50)
Automation (15)
Bankruptcy (111)
Best Places to Work (4936)
BIOSECURE Act (4)
Biosimilars (101)
Biotechnology (21)
Bladder cancer (107)
Brain cancer (31)
Breast cancer (329)
Cancer (2465)
Cardiovascular disease (198)
Career advice (896)
Career pathing (11)
CAR-T (111)
CDC (10)
Cell therapy (308)
Cervical cancer (22)
Clinical research (31397)
Collaboration (710)
Compensation (432)
Complete response letters (12)
COVID-19 (1041)
CRISPR (34)
C-suite (216)
Cystic fibrosis (55)
Data (3212)
Depression (54)
Diabetes (239)
Diagnostics (2396)
Digital health (14)
Diversity (1)
Diversity, equity & inclusion (13)
Drug discovery (95)
Drug pricing (56)
Drug shortages (12)
Duchenne muscular dystrophy (116)
Earnings (52713)
Editorial (17)
Employer branding (10)
Employer resources (43)
Events (35375)
Executive appointments (427)
FDA (8155)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (2)
Frontotemporal dementia (11)
Funding (699)
Gene editing (84)
Generative AI (14)
Gene therapy (241)
GLP-1 (535)
Government (1568)
Grass and pollen (5)
Guidances (349)
Healthcare (6856)
HIV (27)
Huntington's disease (18)
IgA nephropathy (43)
Immunology and inflammation (112)
Immuno-oncology (7)
Indications (39)
Infectious disease (1184)
Inflammatory bowel disease (73)
Inflation Reduction Act (5)
Influenza (73)
Intellectual property (79)
Interviews (197)
IPO (8513)
IRA (11)
Job creations (1186)
Job search strategy (773)
Kidney cancer (13)
Labor market (34)
Layoffs (196)
Leadership (11)
Legal (2110)
Liver cancer (49)
Longevity (5)
Lung cancer (392)
Lymphoma (193)
Machine learning (15)
Management (11)
Manufacturing (274)
MASH (77)
Medical device (5012)
Medtech (5024)
Mergers & acquisitions (6522)
Metabolic disorders (613)
Multiple sclerosis (82)
NASH (11)
Neurodegenerative disease (103)
Neuropsychiatric disorders (30)
Neuroscience (1176)
NextGen: Class of 2025 (2071)
Non-profit (1538)
Now hiring (30)
Obesity (303)
Opinion (79)
Ovarian cancer (75)
Pain (83)
Pancreatic cancer (94)
Parkinson's disease (134)
Partnered (10)
Patents (161)
Patient recruitment (144)
Peanut (30)
People (8835)
Pharmaceutical (11)
Pharmacy benefit managers (8)
Phase I (8436)
Phase II (13515)
Phase III (12044)
Pipeline (2199)
Policy (59)
Postmarket research (1211)
Preclinical (2894)
Press Release (15)
Prostate cancer (134)
Psychedelics (21)
Radiopharmaceuticals (103)
Rare diseases (321)
Real estate (1345)
Recruiting (19)
Regulatory (8394)
Reports (24)
Research institute (795)
Resumes & cover letters (208)
Rett syndrome (13)
RNA editing (2)
RSV (43)
Schizophrenia (78)
Series A (102)
Series B (82)
Service/supplier (3)
Sickle cell disease (41)
Special edition (11)
Spinal muscular atrophy (85)
Sponsored (14)
Startups (1147)
State (1)
Stomach cancer (6)
Supply chain (52)
Tariffs (28)
The Weekly (17)
Vaccines (454)
Venture capital (34)
Weight loss (211)
Women's health (22)
Worklife (9)
Date
Today (142)
Last 7 days (683)
Last 30 days (1917)
Last 365 days (18608)
2025 (15705)
2024 (16897)
2023 (16187)
2022 (20646)
2021 (20272)
2020 (19028)
2019 (16794)
2018 (12749)
2017 (11970)
2016 (10566)
2015 (12716)
2014 (9228)
2013 (7262)
2012 (7941)
2011 (8061)
2010 (7267)
Location
Africa (320)
Alabama (25)
Alaska (2)
Arizona (76)
Arkansas (5)
Asia (15888)
Australia (2427)
California (5475)
Canada (1565)
China (522)
Colorado (214)
Connecticut (295)
Delaware (200)
Europe (35456)
Florida (675)
Georgia (150)
Hawaii (2)
Idaho (17)
Illinois (400)
India (21)
Indiana (248)
Iowa (9)
Japan (243)
Kansas (52)
Kentucky (11)
Louisiana (10)
Maine (44)
Maryland (604)
Massachusetts (3973)
Michigan (107)
Minnesota (249)
Mississippi (2)
Missouri (64)
Montana (8)
Nebraska (4)
Nevada (58)
New Hampshire (29)
New Jersey (1607)
New Mexico (8)
New York (1400)
North Carolina (609)
North Dakota (3)
Northern California (2582)
Ohio (118)
Oklahoma (6)
Oregon (13)
Pennsylvania (980)
Puerto Rico (10)
Rhode Island (16)
South America (466)
South Carolina (15)
Southern California (2071)
Tennessee (68)
Texas (860)
United States (18983)
Utah (118)
Virginia (132)
Washington D.C. (32)
Washington State (502)
West Virginia (3)
Wisconsin (74)
Wyoming (2)
246,420 Results for "5".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Collaboration
Kite Makes $1.5B+ Cell Therapy Pact With Pregene as Others Pull Back
With more than $1.5 billion on the line, Gilead looks to bolster its CAR T portfolio.
October 17, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Palatin Earns €5.5 Million ($6.5 Million) Milestone Payment in Retinal Disease Collaboration with Boehringer Ingelheim
September 23, 2025
·
3 min read
Press Releases
Proton Pump Inhibitors Market Outlook 2025–2032: Strong CAGR of 5.6% with USD 5.90 Billion Valuation
November 3, 2025
·
1 min read
Press Releases
Opus Genetics Reports Positive Pediatric Data from OPGx-LCA5 Phase 1/2 Trial in Leber Congenital Amaurosis Type 5 (LCA5)
October 1, 2025
·
9 min read
Press Releases
Natera Reports Strong Advanced Adenoma Data from Prospective PROCEED-CRC Trial, Demonstrating 22.5% Sensitivity and 91.5% Specificity
October 28, 2025
·
4 min read
Press Releases
Opus Genetics Announces Successful FDA Meeting Supporting Advancement of OPGx-LCA5 Toward Pivotal Trial for LCA5-Related Inherited Retinal Disease
November 6, 2025
·
8 min read
C-suite
The 5 Most Powerful Women in Biopharma
As the industry loses one of its key female leaders in GSK CEO Emma Walmsley,
BioSpace
profiles the women leading the industry’s smaller biopharmas.
October 8, 2025
·
6 min read
·
Annalee Armstrong
C-suite
Novo Nordisk Names New Leader, Cuts 2025 Sales Guidance By 5%
In a surprise double announcement Tuesday, Novo reduced sales guidance by 5%—attributing the change to slowed growth of its semaglutide franchise in the U.S.—and named current international operations head Maziar Mike Doustdar as its new president and CEO.
July 29, 2025
·
2 min read
·
Heather McKenzie
Press Releases
Mineralys Therapeutics to Participate in Upcoming Investor Conferences - November 5, 2025
November 5, 2025
·
1 min read
Mergers & acquisitions
5 SMID-Cap Pharmas Poised for M&A Action
Mergers and acquisitions are not just for Big Pharma. A new report from Leerink Partners takes a stab at identifying the small- to mid-cap pharmas best prepared to bolster their pipelines with a buyout.
October 29, 2025
·
7 min read
·
Annalee Armstrong
1 of 24,642
Next
